Multiple brain abscesses treated by extraction of the maxillary molars with chronic apical lesion to remove the source of infection

por Jung, Ki-Hyun, Ro, Seong-Su, Lee, Seong-Won, Jeon, Jae-Yoon, Park, Chang-Joo, Hwang, Kyung-Gyun
Publicado 2019

Correction to: Multiple brain abscesses treated by extraction of the maxillary molars with chronic apical lesion to remove the source of infection

por Jung, Ki-Hyun, Ro, Seong-Su, Lee, Seong-Won, Jeon, Jae-Yoon, Park, Chang-Joo, Hwang, Kyung-Gyun
Publicado 2019

Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia

por Jarusiewicz, Jamie A., Jeon, Jae Yoon, Connelly, Michele C., Chen, Yizhe, Yang, Lei, Baker, Sharyn D., Guy, R. Kiplin
Publicado 2017

Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia

por Zavorka Thomas, Megan E., Jeon, Jae Yoon, Talebi, Zahra, Buelow, Daelynn R., Silvaroli, Josie, Campbell, Moray J., Sparreboom, Alex, Pabla, Navjot, Baker, Sharyn D.
Publicado 2021

BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors

por Buelow, Daelynn R., Bhatnagar, Bhavana, Orwick, Shelley J., Jeon, Jae Yoon, Eisenmann, Eric D., Stromatt, Jack C., Pabla, Navjot Singh, Blachly, James S., Baker, Sharyn D., Blaser, Bradley W.
Publicado 2022

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

por Eisenmann, Eric D., Stromatt, Jack C., Fobare, Sydney, Huang, Kevin M., Buelow, Daelynn R., Orwick, Shelley, Jeon, Jae Yoon, Weber, Robert H., Larsen, Bill, Mims, Alice S., Hertlein, Erin, Byrd, John C., Baker, Sharyn D.
Publicado 2022

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML

por Drenberg, Christina D., Shelat, Anang, Dang, Jinjun, Cotton, Anitria, Orwick, Shelley J., Li, Mengyu, Jeon, Jae Yoon, Fu, Qiang, Buelow, Daelynn R., Pioso, Marissa, Hu, Shuiying, Inaba, Hiroto, Ribeiro, Raul C., Rubnitz, Jeffrey E., Gruber, Tanja A., Guy, R. Kiplin, Baker, Sharyn D.
Publicado 2019

Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia

por Elgamal, Ola A., Mehmood, Abeera, Jeon, Jae Yoon, Carmichael, Bridget, Lehman, Amy, Orwick, Shelley J., Truxall, Jean, Goettl, Virginia M., Wasmuth, Ronni, Tran, Minh, Mitchell, Shaneice, Lapalombella, Rosa, Eathiraj, Sudharshan, Schwartz, Brian, Stegmaier, Kimberly, Baker, Sharyn D., Hertlein, Erin, Byrd, John C.
Publicado 2020

Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD–Positive AML

por Zavorka Thomas, Megan E., Lu, Xiyuan, Talebi, Zahra, Jeon, Jae Yoon, Buelow, Daelynn R., Gibson, Alice A., Uddin, Muhammad Erfan, Brinton, Lindsey T., Nguyen, Julie, Collins, Meghan, Lodi, Alessia, Sweeney, Shannon R., Campbell, Moray J., Sweet, Douglas H., Sparreboom, Alex, Lapalombella, Rosa, Tiziani, Stefano, Baker, Sharyn D.
Publicado 2021

TP-0903 is active in models of drug-resistant acute myeloid leukemia

por Jeon, Jae Yoon, Buelow, Daelynn R., Garrison, Dominique A., Niu, Mingshan, Eisenmann, Eric D., Huang, Kevin M., Zavorka Thomas, Megan E., Weber, Robert H., Whatcott, Clifford J., Warner, Steve L., Orwick, Shelley J., Carmichael, Bridget, Stahl, Emily, Brinton, Lindsey T., Lapalombella, Rosa, Blachly, James S., Hertlein, Erin, Byrd, John C., Bhatnagar, Bhavana, Baker, Sharyn D.
Publicado 2020